- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Enasidenib, as an IDH2 mutation inhibitor, exerts anti leukemia effects by blocking the production of carcinogenic metabolite 2-HG. Its efficac...
Enasidenib, as an IDH2 mutation inhibitor, is mainly used for the treatment of relapsed/refractory AML. Its efficacy is related to the type of ...
Regorafenib is a multi kinase inhibitor mainly used for the treatment of specific advanced cancers. When using it, attention should be paid to ...
The contraindications, foods, and restrictions of Regorafenib must be strictly followed to ensure the safety and effectiveness of the medicatio...
Tofacitinib, as a JAK inhibitor, is mainly used for the treatment of autoimmune diseases such as rheumatoid arthritis, with significant therape...
Tofacitinib is a JAK inhibitor, and common side effects include increased risk of infection, gastrointestinal reactions, dyslipidemia, etc. In ...
When taking Neratinib, attention should be paid to the impact of diet on drug absorption and adverse reactions. Reasonable dietary adjustments ...
The management of vomiting after taking Neratinib requires different measures based on the time of vomiting, with the core principle being to a...
The use of Darolutamide in special populations requires adjusting the dosage or strengthening monitoring according to individual circumstances,...
Darolutamide is a novel androgen receptor inhibitor primarily used for the treatment of non metastatic castration resistant prostate cancer (nm...
